FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2563188444> ?p ?o ?g. }

• W2563188444 abstract "Abstract Abstract 620 Introduction: The spleen in primary immune thrombocytopenia (ITP) is not only the major site of platelet destruction but is also the main site of auto-antibody production. Accordingly, splenectomy as a second-line treatment has resulted in a durable platelet response in two-thirds of the patients. New strategy, using anti-CD20-induced B-cell depletion (Rituximab, RTX), leads to 40–50% of short term and 20% of long-lasting response. Less is known about B-cell depletion in spleen and the nature of the resistant pathogenic cells. In this study, we analyzed at the population and single cell level the splenic antibody secreting cells, in healthy donors and active chronic ITP patients, treated or not with RTX. Results: We took advantage of these different therapeutic outcomes to analyze the splenic B cell compartment of ITP patients, either not treated with Rituximab (n=5), or treated (n=10) and presenting with a primary failure of the B-cell depletion therapy, and compared them with healthy donors (n=5). Plasma cells (that lack CD20 expression) were the major residual population in spleens from Rituximab-treated patients (0.5% of CD45+ spleen mononuclear cells; range 0.06–1%). A fraction of these plasma cells were autoreactive (0.5–1.2% of IgG secreting cells being anti-GpIIbIIIa specific), thus accounting for the persistence of the disease and the failure of RTX treatment. Using gene profiling and single cell multiplex quantitative RT-PCR (Fluidigm dynamic arrays), we showed that such Rituximab-resistant plasma cells display a unique long-lived transcriptional program, similar to the one of bone marrow plasma cells. In contrast, splenic PC from healthy donors and from untreated ITP patients displayed an intermediate gene expression profile between the ones of long-lived PC and proliferating plasmablasts, with the simultaneous expression of cell cycle genes and survival/anti-apoptotic factors. BAFF secretion was increased two-fold in RTX-spleen supernatants compared to ITP (P<0.05), and might selectively contribute to the survival of the resident RTX-PC population. Conclusion: Our results demonstrate that residual long-lived plasma cells, with a few percents of them secreting anti-GpIIbIIIa antibodies, are found in the spleen 3–6 months following RTX treatment, thus providing a possible explanation for the failure of therapy, and the success of subsequent splenectomy. As opposed to accepted schemes, our data suggest that the normal human spleen is not a niche for long-lived PC, and that auto-immune/inflammatory conditions do not create either a favorable environment for their persistence. We propose in contrast that it is the B-cell depletion itself and the specific cytokinic condition it provides that generates suitable environment for the maturation of long-lived plasma cells in the spleen. This observation suggests that interfering with the differentiation and/or survival of this RTX-induced long-lived plasma cell population could obviate the need for splenectomy in the case of RTX-treatment failure. Disclosures: Off Label Use: rituximab." @default.
• W2563188444 created "2017-01-06" @default.
• W2563188444 creator A5019327395 @default.
• W2563188444 creator A5020417472 @default.
• W2563188444 creator A5020736484 @default.
• W2563188444 creator A5028703971 @default.
• W2563188444 creator A5029604028 @default.
• W2563188444 creator A5031127153 @default.
• W2563188444 creator A5034526107 @default.
• W2563188444 creator A5039260691 @default.
• W2563188444 creator A5041077575 @default.
• W2563188444 creator A5043511133 @default.
• W2563188444 creator A5048851461 @default.
• W2563188444 creator A5049763988 @default.
• W2563188444 creator A5052856500 @default.
• W2563188444 creator A5056136082 @default.
• W2563188444 creator A5057811682 @default.
• W2563188444 creator A5069373819 @default.
• W2563188444 creator A5069583321 @default.
• W2563188444 creator A5085234192 @default.
• W2563188444 creator A5086999065 @default.
• W2563188444 date "2012-11-16" @default.
• W2563188444 modified "2023-10-17" @default.
• W2563188444 title "Emergence of Long-Lived Autoreactive Plasma Cells in the Spleen of ITP Patients Treated with Rituximab" @default.
• W2563188444 doi "https://doi.org/10.1182/blood.v120.21.620.620" @default.
• W2563188444 hasPublicationYear "2012" @default.
• W2563188444 type Work @default.
• W2563188444 sameAs 2563188444 @default.
• W2563188444 citedByCount "0" @default.
• W2563188444 crossrefType "journal-article" @default.
• W2563188444 hasAuthorship W2563188444A5019327395 @default.
• W2563188444 hasAuthorship W2563188444A5020417472 @default.
• W2563188444 hasAuthorship W2563188444A5020736484 @default.
• W2563188444 hasAuthorship W2563188444A5028703971 @default.
• W2563188444 hasAuthorship W2563188444A5029604028 @default.
• W2563188444 hasAuthorship W2563188444A5031127153 @default.
• W2563188444 hasAuthorship W2563188444A5034526107 @default.
• W2563188444 hasAuthorship W2563188444A5039260691 @default.
• W2563188444 hasAuthorship W2563188444A5041077575 @default.
• W2563188444 hasAuthorship W2563188444A5043511133 @default.
• W2563188444 hasAuthorship W2563188444A5048851461 @default.
• W2563188444 hasAuthorship W2563188444A5049763988 @default.
• W2563188444 hasAuthorship W2563188444A5052856500 @default.
• W2563188444 hasAuthorship W2563188444A5056136082 @default.
• W2563188444 hasAuthorship W2563188444A5057811682 @default.
• W2563188444 hasAuthorship W2563188444A5069373819 @default.
• W2563188444 hasAuthorship W2563188444A5069583321 @default.
• W2563188444 hasAuthorship W2563188444A5085234192 @default.
• W2563188444 hasAuthorship W2563188444A5086999065 @default.
• W2563188444 hasConcept C137061746 @default.
• W2563188444 hasConcept C159654299 @default.
• W2563188444 hasConcept C18031839 @default.
• W2563188444 hasConcept C202751555 @default.
• W2563188444 hasConcept C203014093 @default.
• W2563188444 hasConcept C2776309230 @default.
• W2563188444 hasConcept C2776396001 @default.
• W2563188444 hasConcept C2778453870 @default.
• W2563188444 hasConcept C2780653079 @default.
• W2563188444 hasConcept C2780931953 @default.
• W2563188444 hasConcept C2908647359 @default.
• W2563188444 hasConcept C55493867 @default.
• W2563188444 hasConcept C71924100 @default.
• W2563188444 hasConcept C86803240 @default.
• W2563188444 hasConcept C89560881 @default.
• W2563188444 hasConcept C99454951 @default.
• W2563188444 hasConceptScore W2563188444C137061746 @default.
• W2563188444 hasConceptScore W2563188444C159654299 @default.
• W2563188444 hasConceptScore W2563188444C18031839 @default.
• W2563188444 hasConceptScore W2563188444C202751555 @default.
• W2563188444 hasConceptScore W2563188444C203014093 @default.
• W2563188444 hasConceptScore W2563188444C2776309230 @default.
• W2563188444 hasConceptScore W2563188444C2776396001 @default.
• W2563188444 hasConceptScore W2563188444C2778453870 @default.
• W2563188444 hasConceptScore W2563188444C2780653079 @default.
• W2563188444 hasConceptScore W2563188444C2780931953 @default.
• W2563188444 hasConceptScore W2563188444C2908647359 @default.
• W2563188444 hasConceptScore W2563188444C55493867 @default.
• W2563188444 hasConceptScore W2563188444C71924100 @default.
• W2563188444 hasConceptScore W2563188444C86803240 @default.
• W2563188444 hasConceptScore W2563188444C89560881 @default.
• W2563188444 hasConceptScore W2563188444C99454951 @default.
• W2563188444 hasLocation W25631884441 @default.
• W2563188444 hasOpenAccess W2563188444 @default.
• W2563188444 hasPrimaryLocation W25631884441 @default.
• W2563188444 hasRelatedWork W1139999821 @default.
• W2563188444 hasRelatedWork W1581336840 @default.
• W2563188444 hasRelatedWork W1968909135 @default.
• W2563188444 hasRelatedWork W2050619107 @default.
• W2563188444 hasRelatedWork W2121157315 @default.
• W2563188444 hasRelatedWork W2145242843 @default.
• W2563188444 hasRelatedWork W2329570990 @default.
• W2563188444 hasRelatedWork W2360020331 @default.
• W2563188444 hasRelatedWork W2553178734 @default.
• W2563188444 hasRelatedWork W2688203765 @default.
• W2563188444 hasRelatedWork W2790744173 @default.
• W2563188444 hasRelatedWork W2909545308 @default.
• W2563188444 hasRelatedWork W2938757537 @default.
• W2563188444 hasRelatedWork W2979421492 @default.
• W2563188444 hasRelatedWork W2979626316 @default.
• W2563188444 hasRelatedWork W2983103568 @default.

• next